Physician

Infectious Disease

Dr. Alain R. Bouckenooghe, MD

Alain R. Bouckenooghe, MD practices Infectious Disease. He studied medicine at Baylor College of Medicine. Alain Bouckenooghe is a published doctor and has 19 publications published. The lastest was: 'Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 oral suspension (liquid formulation) in Finnish infants.'

Publications

The epidemiology of HIV and AIDS among Central American, South American, and Caribbean immigrants to Houston, Texas.
Highly active antiretroviral treatment in countries with very limited resources: do we have cheaper alternatives?
Enterotoxigenic Escherichia coli as cause of diarrhea among Mexican adults and US travelers in Mexico.
Markers of enteric inflammation in enteroaggregative Escherichia coli diarrhea in travelers.
Psorospermium haeckelii: a cause of pseudoparasitosis.
Intestinal secretory immunoglobulin A response to enteroaggregative Escherichia coli in travelers with diarrhea.
HIV trends in African blood donors.
Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 oral suspension (liquid formulation) in Finnish infants.
Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-...
Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in Europe.
The epidemiology of dengue in the americas over the last three decades: a worrisome reality.
A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children.
Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrat...
Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a ...
Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study.
Efficacy of the human rotavirus vaccine RIX4414 in malnourished children.
Introduction of human rotavirus vaccine in Latin America.
Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.

Schools

Catholic University Leuven Faculty of Medicine
University Tex Houston
Hermann Hospital University Tex Houston

Doctors Specialties

Infectious Disease Medicine
Infectious Disease

Accepted Insurances

Education

Baylor College of Medicine
University of Texas Health Science Center

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Kashif A. Memon, MD This Doctor is OpenDoctor Recommended.
	Dr. Mary G. Mooers, MD This Doctor is OpenDoctor Recommended.
	Dr. David C. Classen, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Larry Reimer, MD This Doctor is OpenDoctor Recommended.
	Dr. Kimberly Hanson, MD This Doctor is OpenDoctor Recommended.
	Dr. Stephanie S. Gelman, MD This Doctor is OpenDoctor Recommended.
	Dr. Jeanmarie Mayer, MD This Doctor is OpenDoctor Recommended.
	Dr. Andrew T. Pavia, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Charles B. Smith, MD This Doctor is OpenDoctor Recommended.
	Dr. Phil H. Alday Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. John B. Hibbs Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. Michael A. Rubin, MD This Doctor is OpenDoctor Recommended.